FAKTOR-OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 18:27:16 20/06/2024 BST | ||
| 0.001 EUR | 0.00% |
|
| 6 months | -99.99% | ||
| Current year | -99.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 0.001 | 0.00% |
| 19/06/24 | 0.001 | 0.00% |
| 18/06/24 | 0.001 | 0.00% |
| 17/06/24 | 0.001 | 0.00% |
| 14/06/24 | 0.001 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 20, 2024 at 06:27 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SU0NZ4 |
| ISIN | DE000SU0NZ41 |
| Date issued | 13/10/2023 |
| Strike | 283.9 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.24 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.37 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306
USD
Average target price
316.4
USD
Spread / Average Target
+3.42%
- Stock Market
- Certificates
- Certificat
